Compare 10X Genomics Inc (TXG) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vanguard Short Term Corporate Bond ETF trades at $78.58. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| TXG | VCSH | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Fixed Income |
52-Week High | $45.80 | $80.20 |
52-Week Low | $11.34 | $78.45 |
Enterprise Value | $5.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VCSH trades at $78.64, down 0.1% on the day, with a bearish technical signal driven by moving averages. The ETF maintains a steady dividend payout, with recent distributions of $0.29-$0.30 per share. News highlights institutional activity, including Allspring Global Investments purchasing 1.47 million shares in July 2026. The fund's focus on short-term corporate bonds offers a higher yield compared to treasury alternatives, though it carries greater credit risk.
The outlook for VCSH is mixed, balancing income appeal against interest rate sensitivity. Opportunities include attractive yield and low expense ratio, while risks involve Fed policy uncertainty and credit spread volatility. Investors seeking short-duration corporate exposure may find value, but should monitor rate expectations and economic conditions closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
